Bandaram Pharma Packtech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve Unaudited financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bandaram Pharma Packtech Ltd has informed BSE that its Board of Directors will meet on Friday, 13 February 2026 at the registered office. The main agenda is to consider and approve the unaudited standalone and consolidated financial results for the quarter and nine months ended 31 December 2025 (Q3 FY26). The notice also includes the standard 'any other business with the permission of the Chair' clause. The intimation was signed by Chairman and Managing Director B. Deepak Reddy on 3 February 2026.
No immediate impact on shareholders — this is a routine advance intimation required before announcing quarterly results. Investors should watch for the actual Q3 FY26 numbers, which could move the stock once released after the board meeting.